| Q74510523 | A central role for protein kinase C overactivity in diabetic glomerulosclerosis: implications for prevention with antioxidants, fish oil, and ACE inhibitors |
| Q37048746 | A prospective controlled study of kidney donors: baseline and 6-month follow-up |
| Q35797926 | A prospective controlled study of living kidney donors: three-year follow-up |
| Q80087064 | Autonomic dysregulation as a basis of cardiovascular, endocrine, and inflammatory disturbances associated with obstructive sleep apnea and other conditions of chronic hypoxia, hypercapnia, and acidosis |
| Q37667575 | Chronic kidney disease, exercise, and sports in children, adolescents, and adults |
| Q35466376 | Correlates of insulin resistance in older individuals with and without kidney disease |
| Q73957497 | Dietary protein restriction in combination with angiotensin converting enzyme inhibitor improves insulin resistance in patients with chronic renal disease |
| Q54153329 | Inhibition of glucose uptake by 5-hydroxyindoleacetic acid in the isolated rat soleus muscle. |
| Q28371370 | Inhibitory effect of troglitazone on tumor necrosis factor alpha-induced expression of monocyte chemoattractant protein-1 in human mesangial cells |
| Q61853244 | Insulin Resistance, Inflammation, and Vascular Disease in Nondiabetic Predialysis Chronic Kidney Disease Patients |
| Q64264442 | Insulin resistance and chronic kidney disease progression, cardiovascular events, and death: findings from the chronic renal insufficiency cohort study |
| Q30244271 | Insulin resistance in chronic kidney disease: a systematic review |
| Q51554628 | Insulin resistance in diabetic microangiopathies. |
| Q73006796 | Plasminogen activator inhibitor-1 activity in chronic renal disease and dialysis |
| Q36417652 | Skeletal muscle dysfunction in chronic renal failure: effects of exercise |
| Q44981409 | Vitamin D deficiency, insulin resistance, and ventricular hypertrophy in the early stages of chronic kidney disease |